The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Afatinib Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Afatinib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Afatinib market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Afatinib global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 30mg Tables segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Afatinib include Boehringer Ingelheim, Hengrui Medicine, Beacon Pharma, , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Afatinib market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
30mg Tables
40mg Tables
50mg Tables
25mg Tables
20mg Tables
Other
Market segment by Application, can be divided into
Hospital
Clinic
Drug Center
Other
Market segment by players, this report covers
Boehringer Ingelheim
Hengrui Medicine
Beacon Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Afatinib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Afatinib, with revenue, gross margin and global market share of Afatinib from 2019 to 2022.
Chapter 3, the Afatinib competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Afatinib market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Afatinib research findings and conclusion, appendix and data source.
Geographical Area
Global
The Afatinib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Afatinib market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Afatinib global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 30mg Tables segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Afatinib include Boehringer Ingelheim, Hengrui Medicine, Beacon Pharma, , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Afatinib market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
30mg Tables
40mg Tables
50mg Tables
25mg Tables
20mg Tables
Other
Market segment by Application, can be divided into
Hospital
Clinic
Drug Center
Other
Market segment by players, this report covers
Boehringer Ingelheim
Hengrui Medicine
Beacon Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Afatinib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Afatinib, with revenue, gross margin and global market share of Afatinib from 2019 to 2022.
Chapter 3, the Afatinib competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Afatinib market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Afatinib research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Afatinib
1.2 Classification of Afatinib by Type
1.2.1 Overview: Global Afatinib Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Afatinib Revenue Market Share by Type in 2021
1.2.3 30mg Tables
1.2.4 40mg Tables
1.2.5 50mg Tables
1.2.6 25mg Tables
1.2.7 20mg Tables
1.2.8 Other
1.3 Global Afatinib Market by Application
1.3.1 Overview: Global Afatinib Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Global Afatinib Market Size & Forecast
1.5 Global Afatinib Market Size and Forecast by Region
1.5.1 Global Afatinib Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Afatinib Market Size by Region, (2017-2022)
1.5.3 North America Afatinib Market Size and Prospect (2017-2028)
1.5.4 Europe Afatinib Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Afatinib Market Size and Prospect (2017-2028)
1.5.6 South America Afatinib Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Afatinib Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Afatinib Market Drivers
1.6.2 Afatinib Market Restraints
1.6.3 Afatinib Trends Analysis
2 Company Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Afatinib Product and Solutions
2.1.4 Boehringer Ingelheim Afatinib Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Boehringer Ingelheim Recent Developments and Future Plans
2.2 Hengrui Medicine
2.2.1 Hengrui Medicine Details
2.2.2 Hengrui Medicine Major Business
2.2.3 Hengrui Medicine Afatinib Product and Solutions
2.2.4 Hengrui Medicine Afatinib Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Hengrui Medicine Recent Developments and Future Plans
2.3 Beacon Pharma
2.3.1 Beacon Pharma Details
2.3.2 Beacon Pharma Major Business
2.3.3 Beacon Pharma Afatinib Product and Solutions
2.3.4 Beacon Pharma Afatinib Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Beacon Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Afatinib Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Afatinib Players Market Share in 2021
3.2.2 Top 10 Afatinib Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Afatinib Players Head Office, Products and Services Provided
3.4 Afatinib Mergers & Acquisitions
3.5 Afatinib New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Afatinib Revenue and Market Share by Type (2017-2022)
4.2 Global Afatinib Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Afatinib Revenue Market Share by Application (2017-2022)
5.2 Global Afatinib Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Afatinib Revenue by Type (2017-2028)
6.2 North America Afatinib Revenue by Application (2017-2028)
6.3 North America Afatinib Market Size by Country
6.3.1 North America Afatinib Revenue by Country (2017-2028)
6.3.2 United States Afatinib Market Size and Forecast (2017-2028)
6.3.3 Canada Afatinib Market Size and Forecast (2017-2028)
6.3.4 Mexico Afatinib Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Afatinib Revenue by Type (2017-2028)
7.2 Europe Afatinib Revenue by Application (2017-2028)
7.3 Europe Afatinib Market Size by Country
7.3.1 Europe Afatinib Revenue by Country (2017-2028)
7.3.2 Germany Afatinib Market Size and Forecast (2017-2028)
7.3.3 France Afatinib Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Afatinib Market Size and Forecast (2017-2028)
7.3.5 Russia Afatinib Market Size and Forecast (2017-2028)
7.3.6 Italy Afatinib Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Afatinib Revenue by Type (2017-2028)
8.2 Asia-Pacific Afatinib Revenue by Application (2017-2028)
8.3 Asia-Pacific Afatinib Market Size by Region
8.3.1 Asia-Pacific Afatinib Revenue by Region (2017-2028)
8.3.2 China Afatinib Market Size and Forecast (2017-2028)
8.3.3 Japan Afatinib Market Size and Forecast (2017-2028)
8.3.4 South Korea Afatinib Market Size and Forecast (2017-2028)
8.3.5 India Afatinib Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Afatinib Market Size and Forecast (2017-2028)
8.3.7 Australia Afatinib Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Afatinib Revenue by Type (2017-2028)
9.2 South America Afatinib Revenue by Application (2017-2028)
9.3 South America Afatinib Market Size by Country
9.3.1 South America Afatinib Revenue by Country (2017-2028)
9.3.2 Brazil Afatinib Market Size and Forecast (2017-2028)
9.3.3 Argentina Afatinib Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Afatinib Revenue by Type (2017-2028)
10.2 Middle East & Africa Afatinib Revenue by Application (2017-2028)
10.3 Middle East & Africa Afatinib Market Size by Country
10.3.1 Middle East & Africa Afatinib Revenue by Country (2017-2028)
10.3.2 Turkey Afatinib Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Afatinib Market Size and Forecast (2017-2028)
10.3.4 UAE Afatinib Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Afatinib Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Afatinib Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Afatinib Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Afatinib Revenue (USD Million) by Region (2017-2022)
Table 5. Global Afatinib Revenue Market Share by Region (2023-2028)
Table 6. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 7. Boehringer Ingelheim Major Business
Table 8. Boehringer Ingelheim Afatinib Product and Solutions
Table 9. Boehringer Ingelheim Afatinib Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Hengrui Medicine Corporate Information, Head Office, and Major Competitors
Table 11. Hengrui Medicine Major Business
Table 12. Hengrui Medicine Afatinib Product and Solutions
Table 13. Hengrui Medicine Afatinib Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Beacon Pharma Corporate Information, Head Office, and Major Competitors
Table 15. Beacon Pharma Major Business
Table 16. Beacon Pharma Afatinib Product and Solutions
Table 17. Beacon Pharma Afatinib Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Global Afatinib Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 19. Global Afatinib Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 20. Breakdown of Afatinib by Company Type (Tier 1, Tier 2 and Tier 3)
Table 21. Afatinib Players Head Office, Products and Services Provided
Table 22. Afatinib Mergers & Acquisitions in the Past Five Years
Table 23. Afatinib New Entrants and Expansion Plans
Table 24. Global Afatinib Revenue (USD Million) by Type (2017-2022)
Table 25. Global Afatinib Revenue Share by Type (2017-2022)
Table 26. Global Afatinib Revenue Forecast by Type (2023-2028)
Table 27. Global Afatinib Revenue by Application (2017-2022)
Table 28. Global Afatinib Revenue Forecast by Application (2023-2028)
Table 29. North America Afatinib Revenue by Type (2017-2022) & (USD Million)
Table 30. North America Afatinib Revenue by Type (2023-2028) & (USD Million)
Table 31. North America Afatinib Revenue by Application (2017-2022) & (USD Million)
Table 32. North America Afatinib Revenue by Application (2023-2028) & (USD Million)
Table 33. North America Afatinib Revenue by Country (2017-2022) & (USD Million)
Table 34. North America Afatinib Revenue by Country (2023-2028) & (USD Million)
Table 35. Europe Afatinib Revenue by Type (2017-2022) & (USD Million)
Table 36. Europe Afatinib Revenue by Type (2023-2028) & (USD Million)
Table 37. Europe Afatinib Revenue by Application (2017-2022) & (USD Million)
Table 38. Europe Afatinib Revenue by Application (2023-2028) & (USD Million)
Table 39. Europe Afatinib Revenue by Country (2017-2022) & (USD Million)
Table 40. Europe Afatinib Revenue by Country (2023-2028) & (USD Million)
Table 41. Asia-Pacific Afatinib Revenue by Type (2017-2022) & (USD Million)
Table 42. Asia-Pacific Afatinib Revenue by Type (2023-2028) & (USD Million)
Table 43. Asia-Pacific Afatinib Revenue by Application (2017-2022) & (USD Million)
Table 44. Asia-Pacific Afatinib Revenue by Application (2023-2028) & (USD Million)
Table 45. Asia-Pacific Afatinib Revenue by Region (2017-2022) & (USD Million)
Table 46. Asia-Pacific Afatinib Revenue by Region (2023-2028) & (USD Million)
Table 47. South America Afatinib Revenue by Type (2017-2022) & (USD Million)
Table 48. South America Afatinib Revenue by Type (2023-2028) & (USD Million)
Table 49. South America Afatinib Revenue by Application (2017-2022) & (USD Million)
Table 50. South America Afatinib Revenue by Application (2023-2028) & (USD Million)
Table 51. South America Afatinib Revenue by Country (2017-2022) & (USD Million)
Table 52. South America Afatinib Revenue by Country (2023-2028) & (USD Million)
Table 53. Middle East & Africa Afatinib Revenue by Type (2017-2022) & (USD Million)
Table 54. Middle East & Africa Afatinib Revenue by Type (2023-2028) & (USD Million)
Table 55. Middle East & Africa Afatinib Revenue by Application (2017-2022) & (USD Million)
Table 56. Middle East & Africa Afatinib Revenue by Application (2023-2028) & (USD Million)
Table 57. Middle East & Africa Afatinib Revenue by Country (2017-2022) & (USD Million)
Table 58. Middle East & Africa Afatinib Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Afatinib Picture
Figure 2. Global Afatinib Revenue Market Share by Type in 2021
Figure 3. 30mg Tables
Figure 4. 40mg Tables
Figure 5. 50mg Tables
Figure 6. 25mg Tables
Figure 7. 20mg Tables
Figure 8. Other
Figure 9. Afatinib Revenue Market Share by Application in 2021
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Drug Center Picture
Figure 13. Other Picture
Figure 14. Global Afatinib Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 15. Global Afatinib Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Afatinib Revenue Market Share by Region (2017-2028)
Figure 17. Global Afatinib Revenue Market Share by Region in 2021
Figure 18. North America Afatinib Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Europe Afatinib Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Asia-Pacific Afatinib Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. South America Afatinib Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Middle East and Africa Afatinib Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Afatinib Market Drivers
Figure 24. Afatinib Market Restraints
Figure 25. Afatinib Market Trends
Figure 26. Boehringer Ingelheim Recent Developments and Future Plans
Figure 27. Hengrui Medicine Recent Developments and Future Plans
Figure 28. Beacon Pharma Recent Developments and Future Plans
Figure 29. Global Afatinib Revenue Share by Players in 2021
Figure 30. Afatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 31. Global Top 3 Players Afatinib Revenue Market Share in 2021
Figure 32. Global Top 10 Players Afatinib Revenue Market Share in 2021
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 34. Global Afatinib Revenue Share by Type in 2021
Figure 35. Global Afatinib Market Share Forecast by Type (2023-2028)
Figure 36. Global Afatinib Revenue Share by Application in 2021
Figure 37. Global Afatinib Market Share Forecast by Application (2023-2028)
Figure 38. North America Afatinib Sales Market Share by Type (2017-2028)
Figure 39. North America Afatinib Sales Market Share by Application (2017-2028)
Figure 40. North America Afatinib Revenue Market Share by Country (2017-2028)
Figure 41. United States Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Afatinib Sales Market Share by Type (2017-2028)
Figure 45. Europe Afatinib Sales Market Share by Application (2017-2028)
Figure 46. Europe Afatinib Revenue Market Share by Country (2017-2028)
Figure 47. Germany Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Afatinib Sales Market Share by Type (2017-2028)
Figure 53. Asia-Pacific Afatinib Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Afatinib Revenue Market Share by Region (2017-2028)
Figure 55. China Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. South Korea Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Afatinib Sales Market Share by Type (2017-2028)
Figure 62. South America Afatinib Sales Market Share by Application (2017-2028)
Figure 63. South America Afatinib Revenue Market Share by Country (2017-2028)
Figure 64. Brazil Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Argentina Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Middle East and Africa Afatinib Sales Market Share by Type (2017-2028)
Figure 67. Middle East and Africa Afatinib Sales Market Share by Application (2017-2028)
Figure 68. Middle East and Africa Afatinib Revenue Market Share by Country (2017-2028)
Figure 69. Turkey Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Saudi Arabia Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. UAE Afatinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
